At BAST we offer the full range of PK analysis support ranging from non-compartmental analysis over non-linear mixed effect models to physiologically based PK models of small molecule compounds and biologics.
In the past, our work has guided the clinical development of our clients’ drugs in numerous ways. From assessing the sources and effects of inter-patient variability to the design of optimally powered bioequivalence studies according to regulatory guidelines BAST has provided valuable contributions to its clients.
Contact us for more information or a quote, if you think that our services will be of help to you!
